Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen : Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice
Damu, Y.A.N.G.; Holt, G.E.; Velders, M.P.; Kwon, E.D.; Kast, W.M.
Cancer Research (Baltimore) 61(15): 5857-5860
2001
ISSN/ISBN: 0008-5472
Accession: 076756577
PDF emailed within 1 workday: $29.90
Related References
Yang, D.; Holt, G.E.; Velders, M.P.; Kwon, E.D.; Kast, W.M. 2001: Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice Cancer Research 61(15): 5857-5860Hara, N.; Kasahara, T.; Kawasaki, T.; Bilim, V.; Obara, K.; Takahashi, K.; Tomita, Y. 2002: Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(6): 1794-1799
Christiansen, J.J.; Rajasekaran, S.A.; Moy, P.; Butch, A.; Goodglick, L.; Gu, Z.; Reiter, R.E.; Bander, N.H.; Rajasekaran, A.K. 2003: Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line Prostate 55(1): 9-19
Taylor, R.M.; Severns, V.; Brown, D.C.; Bisoffi, M.; Sillerud, L.O. 2012: Prostate CancerTargeting Motifs: Expression of ανβ3, Neurotensin Receptor I, Prostate Specific Membrane Antigen, and Prostate Stem Cell Antigen in Human Prostate Cancer Cell Lines and Xenografts The Prostate 72(5): 523-532
Morote, J.; Raventós, C.X.; Lorente, J.A.; Lopez-Pacios, M.A.; Encabo, G.; de Torres, I.; Andreu, J. 1997: Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml Journal of Urology 158(2): 502-504
Taylor, R.M.; Severns, V.; Brown, D.C.; Bisoffi, M.; Sillerud, L.O. 2012: Prostate cancer targeting motifs: expression of αν β3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts Prostate 72(5): 523-532
Christiansen, J.J.; Rajasekaran, S.A.; Moy, P.; Butch, A.; Goodglick, L.; Zhennan, G.U.; Reiter, R.E.; Bander, N.H.; Rajasekaran, A.K. 2003: Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostatetissue and in a cultured epithelial cell line The Prostate 55(1): 9-19
Auprich, M.; Augustin, H.; Budäus, L.; Kluth, L.; Mannweiler, S.; Shariat, S.F.; Fisch, M.; Graefen, M.; Pummer, K.; Chun, F.K.-H. 2012: A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy Bju International 109(11): 1627-1635
Horn, T.; Krönke, M.; Rauscher, I.; Haller, B.; Robu, S.; Wester, H.-J.ür.; Schottelius, M.; van Leeuwen, F.W.B.; van der Poel, H.G.; Heck, M.; Gschwend, J.ür.E.; Weber, W.; Eiber, M.; Maurer, T. 2019: Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer European Urology 76(4): 517-523
Ananias, H.J.K.; van den Heuvel, M.C.; Helfrich, W.; de Jong, I.J. 2009: Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer Prostate 69(10): 1101-1108
Ross, S.; Spencer, S.D.; Lasky, L.A.; Koeppen, H. 2001: Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis American Journal of Pathology 158(3): 809-816
Arndt, C.; Feldmann, A.; Koristka, S.; Cartellieri, M.; Dimmel, M.; Ehninger, A.; Ehninger, G.; Bachmann, M. 2014: Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system Prostate 74(13): 1335-1346
Chiang, I.-N.; Chang, S.-J.; Pu, Y.-S.; Huang, K.-H.; Yu, H.-J.; Huang, C.-Y. 2009: Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection Urologia Internationalis 82(3): 270-275
Catalona, W.J.; Partin, A.W.; Sanda, M.G.; Wei, J.T.; Klee, G.G.; Bangma, C.H.; Slawin, K.M.; Marks, L.S.; Loeb, S.; Broyles, D.L.; Shin, S.S.; Cruz, A.B.; Chan, D.W.; Sokoll, L.J.; Roberts, W.L.; van Schaik, R.H.N.; Mizrahi, I.A. 2011: A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range Journal of Urology 185(5): 1650-1655
Kuroda, K.; Liu, H.; Kim, S.; Guo, M.; Navarro, V.; Bander, N.H. 2009: Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy Prostate 69(14): 1579-1585
Garrido, M.M.; Marta, J.é C.; Bernardino, R.M.; Guerra, J.ão.; Fernandes, F.; Pereira, M.H.; Ribeiro, R.; Holdenrieder, S.; Pinheiro, L.ís.C.; Guimarães, J.ão.T. 2022: The Percentage of [-2]Pro-Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and can be Used as Reflex Tests Archives of Pathology and Laboratory Medicine 146(6): 691-700
Lein, M.; Jung, K.; Elgeti, U.; Petras, T.; Stephan, C.; Brux, B.; Sinha, P.; Winkelmann, B.; Schnorr, D.; Loening, S. 2001: Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis European Urology 39(1): 57-64
Jung, K.; Brux, B.; Knäbich, A.; Lein, M.; Sinha, P.; Schnorr, D.; Loening, S.A. 1999: A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia Clinical Chemistry 45(3): 422-424
Bacich, D.J.; Harsch, K.M.; Heston, W.D.W. 2002: Transgenic mice expressing human Prostate-Specific Membrane Antigen in their prostate A potential model for prostate cancer initiation, development and therapy Proceedings of the American Association for Cancer Research Annual Meeting 43: 312-313
Crook, J.M.; Bahadur, Y.A.; Bociek, R.G.; Perry, G.A.; Robertson, S.J.; Esche, B.A. 1997: Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen Cancer 79(2): 328-336